IRIS
PACELLI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.437
NA - Nord America 1.251
AS - Asia 994
SA - Sud America 155
Continente sconosciuto - Info sul continente non disponibili 95
AF - Africa 68
OC - Oceania 4
Totale 4.004
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.193
IT - Italia 469
RU - Federazione Russa 411
SG - Singapore 298
CN - Cina 268
IE - Irlanda 158
BR - Brasile 128
GB - Regno Unito 120
VN - Vietnam 91
HK - Hong Kong 68
BD - Bangladesh 61
KR - Corea 60
FR - Francia 59
DE - Germania 54
IN - India 52
FI - Finlandia 40
SE - Svezia 39
CA - Canada 33
ZA - Sudafrica 29
NL - Olanda 18
PK - Pakistan 18
UA - Ucraina 15
EG - Egitto 14
IQ - Iraq 14
MX - Messico 14
AR - Argentina 12
ES - Italia 12
PL - Polonia 12
IR - Iran 11
BE - Belgio 9
JP - Giappone 9
KE - Kenya 8
AT - Austria 6
SA - Arabia Saudita 6
CR - Costa Rica 5
MA - Marocco 5
TR - Turchia 5
AU - Australia 4
CZ - Repubblica Ceca 4
ID - Indonesia 4
UZ - Uzbekistan 4
CI - Costa d'Avorio 3
CO - Colombia 3
MY - Malesia 3
PY - Paraguay 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
DZ - Algeria 2
EC - Ecuador 2
GE - Georgia 2
JO - Giordania 2
KH - Cambogia 2
LK - Sri Lanka 2
NG - Nigeria 2
OM - Oman 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CL - Cile 1
CU - Cuba 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 3.909
Salva come PNG Salva come JPEG
Città #
Singapore 184
Dublin 155
San Jose 148
Moscow 112
Ashburn 111
Dallas 109
Hefei 101
Milan 88
Santa Clara 88
Southend 81
Council Bluffs 67
Hong Kong 64
Seoul 56
Siena 55
Beijing 47
Fairfield 45
Florence 43
Los Angeles 42
Chandler 34
New York 33
Rome 33
Ho Chi Minh City 29
Lauterbourg 28
Munich 26
Johannesburg 25
Helsinki 23
Ann Arbor 22
Columbus 21
São Paulo 20
Houston 19
Seattle 19
Hanoi 18
Turin 17
Woodbridge 17
The Dalles 15
Bengaluru 14
Shanghai 14
Chennai 13
Cambridge 12
London 12
Toronto 12
Buffalo 11
Lappeenranta 9
Warsaw 9
Cairo 8
Denver 8
Dong Ket 8
Figino 8
Genoa 8
Jacksonville 8
Nuremberg 8
Orem 8
Princeton 8
Turku 8
Wilmington 8
Baghdad 7
Boardman 7
Boston 7
Dearborn 7
Frankfurt am Main 7
Montreal 7
Redondo Beach 7
Brooklyn 6
Cagliari 6
Düsseldorf 6
Mumbai 6
Atlanta 5
Da Nang 5
Dhaka 5
Messina 5
Portsmouth 5
San Diego 5
San José 5
Stockholm 5
Biên Hòa 4
Bologna 4
Brussels 4
Fano 4
Guangzhou 4
Nanjing 4
Naples 4
Padova 4
Paris 4
Phoenix 4
Pisa 4
Rio de Janeiro 4
Tashkent 4
Tokyo 4
Vancouver 4
Vienna 4
Abidjan 3
Brescia 3
Charlotte 3
Chicago 3
Colombo 3
Corsico 3
Curitiba 3
Gussago 3
Haiphong 3
Lahore 3
Totale 2.396
Salva come PNG Salva come JPEG
Nome #
Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia 322
Circulating CD34+/CD38-/CD26+ Leukemia Stem Cells along Chronic Myeloid Leukemia progression: differences between Chronic, Accelerated and Blast Phase 315
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 302
Evaluation of Multiple Myeloma Minimal Residual Disease by using Next Generation Flow in patients undergoing Daratumumab consolidation therapy 300
Anti CD38 monoclonal antibodies for multiple myeloma treatment 210
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies 196
Minimal residual disease in multiple myeloma: State of the art and applications in clinical practice 195
Prospective monitoring of Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation: the fate of Peripheral Blood CD26+ Leukemia Stem Cells 187
Drug resistance and minimal residual disease in multiple myeloma 168
Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS) 163
DART4MM: Daratumumab as Consolidation Therapy in Patients who Already Achieved Optimal Response/MRD Positivity by Next Generation Flow (NGF): Preliminary Results of a Phase 2 Multicenter Study 161
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 161
Anti-BCMA novel therapies for multiple myeloma 152
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study 150
Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia 148
Long-term CR Multiple Myeloma Patients Show Cured or MGUS-like Minimal Residual Disease Pattern by Next Generation Flow 143
“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow 141
Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation 140
Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies 136
Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study 99
Low rate of infectious mortality omitting fluoroquinolone prophylaxis in high-risk hematological patients, a single centre experience 74
Tracking leukemic residuals: dissecting the inverse relationship between CD26+ stem cells and extracellular BCR::ABL1 transcript in Chronic Myeloid Leukemia (CML) 53
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM 37
Reply to “Peripheral blood CD26+ leukemic stem cells in chronic myeloid leukemia and tyrosine kinase inhibitor response: Questions remain!” 35
Bone marrow immune cell composition reflects multiple myeloma progression and affects treatment response 16
Totale 4.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.669
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202291 0 0 3 0 8 1 3 13 11 13 25 14
2022/2023207 8 17 16 18 10 20 7 33 16 9 40 13
2023/2024406 22 20 33 30 30 67 118 16 4 21 15 30
2024/2025775 38 28 94 34 86 41 21 38 79 50 88 178
2025/20261.966 130 227 152 261 377 75 199 62 65 118 104 196
2026/2027259 119 81 59 0 0 0 0 0 0 0 0 0
Totale 4.004